---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000866"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:17:30.113937+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences posts investor video by CSO on DNase I oncology preclinical data

## Summary
- Chief Scientific Officer Curis Lockshin, PhD, discusses preclinical data from DNase I oncology platform.
- Video available at https://www.virtualinvestorco.com/wtm-xbio-8k.
- No financial results, guidance, or material business changes disclosed.

## SEC filing metadata
- accession: 0001683168-24-000866
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/0001683168-24-000866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000866
- JSON: https://secwatch.observer/filing/0001683168-24-000866.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000866.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.